Full-Time

Responsible Data & AI Program Lead

Posted on 10/25/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Toronto, ON, Canada

Onsite presence required.

Category
Data Management
Data Science
Data & Analytics
Required Skills
Data Science
Data Analysis
Requirements
  • Minimum of 5 years of relevant experience, with a proven track record in strategy and transformation/implementation of large-scale AI programs.
  • Understanding of, and interest in, the evolving AI regulatory landscape and emerging Responsible AI governance and compliance requirements.
  • Demonstrated experience in data and analytics/management consulting with a focus on Data Governance and Responsible AI preferred.
  • Proficiency in techno-functional data capabilities such as security, privacy, cloud, data science, with a specific emphasis on responsible data practices.
  • Proficiency in Data Governance (metadata management, data quality, data access, master data) and AI/ML (model management, model serving, MLOps) concepts and implementations.
  • Bachelor’s/Master’s/PhD in business, STEM (science, technology, engineering, mathematics), or equivalent experience, with preferred experience in standing up Responsible AI principles and practices.
  • Certification in PMP, ASM-Agile Scrum Master, Certified Scrum Master/Product Owner (CSM, CSPO, SAFe) preferred, with a solid understanding of agile.
  • English (fluent) mandatory.
Responsibilities
  • Lead the definition of the Responsible AI team’s roadmap, ensuring clarity, budget alignment, resource allocation, and strategic alignment with Sanofi's evolving priorities.
  • Serve as the central RAISE team leader, owning the strategic direction and program management of major Responsible Data & AI initiatives across communications, upskilling, risk management processes, and governance.
  • Collaborate closely with platform product owners to synchronize on tooling and technologies.
  • Collaborate closely with Data & AI product owners and developers to define and adopt technical controls that will allow for responsibility-by-design.
  • Drive and monitor global business adoption of responsible Data & AI standards in a governance office structure, leading steering committees, councils and focus groups with a diverse set of stakeholders.
  • Engage Sanofi resources around the world in increasing the responsible Data & AI literacy and awareness and adoption of communications and upskilling.
  • Facilitate the scalable deployment of responsible Data & AI processes across various Global Business Units and functional areas.
  • Mobilize and leverage resources across the organization to ensure the successful delivery of Responsible Data & AI priorities and objectives.
  • Oversee the day-to-day business operations for the Responsible Data & AI portfolio, integrating seamlessly with its network of specialists across Legal, Privacy, Ethics, Digital, Social Responsibility, etc.
  • Define and implement a long-term sustainable global operating model for Data & AI governance.
  • Influence Sanofi’s policies and external thought leadership on Responsible Data & AI.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tolebrutinib's FDA Breakthrough Therapy designation boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval for young children expands Sanofi's pediatric market.
  • Sanofi's partnership with BrightInsight accelerates digital health solution development.

What critics are saying

  • Liver enzyme elevations in tolebrutinib patients may affect market acceptance.
  • Increased competition in rare diseases from biotech startups challenges Sanofi.
  • Regulatory delays could impact Dupixent's approval for chronic spontaneous urticaria.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE